NCT07293650

Brief Summary

The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question\[s\] it aims to answer \[is/are\]:

  • Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
  • Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut. Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
372

participants targeted

Target at P50-P75 for phase_3

Timeline
73mo left

Started Apr 2026

Longer than P75 for phase_3

Geographic Reach
1 country

15 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Apr 2026Aug 2032

First Submitted

Initial submission to the registry

December 17, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 19, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

April 29, 2026

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2031

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2032

Last Updated

July 27, 2026

Status Verified

July 1, 2026

Enrollment Period

5.3 years

First QC Date

December 17, 2025

Last Update Submit

July 24, 2026

Conditions

Keywords

achalasiaEGJOO

Outcome Measures

Primary Outcomes (4)

  • Clinical Response-Overall

    Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

    From enrollment to Year 2

  • Clinical Response-by Sex

    Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

    From enrollment to Year 2

  • Clinical Response-by Race

    Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

    From Enrollment to Year 2

  • Clinical Response-by Ethnicity

    Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years.

    From Enrollment to Year 2

Study Arms (2)

Standard Myotomy

ACTIVE COMPARATOR
Procedure: Standard Myotomy

Tailored Short Myotomy

EXPERIMENTAL
Procedure: Tailored Short Myotomy

Interventions

Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy.

Standard Myotomy

Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy.

Tailored Short Myotomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18
  • Type I achalasia or type II achalasia or cEGJOO
  • Eckardt score \> 3

You may not qualify if:

  • Prior POEM
  • Prior surgical treatment for achalasia
  • Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
  • Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
  • Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
  • Known secondary achalasia related to malignancy (pseudoachalasia)
  • Known eosinophilic esophagitis
  • Diverticulum (\> 2 cm) in distal esophagus
  • Megaesophagus
  • Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
  • Pregnancy
  • Standard contraindications to general anesthesia
  • Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
  • Unwillingness or inability to consent for the study
  • Anticipated inability to follow protocol
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (15)

Mayo Clinic Arizona

Scottsdale, Arizona, 85259, United States

NOT YET RECRUITING

University of California San Diego

La Jolla, California, 92093, United States

NOT YET RECRUITING

University of Colorado Denver

Denver, Colorado, 80217, United States

NOT YET RECRUITING

University of Florida

Gainesville, Florida, 32611, United States

NOT YET RECRUITING

Adventist Health System/Sunbelt, Inc

Orlando, Florida, 32803, United States

NOT YET RECRUITING

Emory University

Atlanta, Georgia, 30322, United States

NOT YET RECRUITING

Northwestern University

Chicago, Illinois, 60611, United States

RECRUITING

Johns Hopkins University

Baltimore, Maryland, 21218, United States

NOT YET RECRUITING

Washington University

St Louis, Missouri, 63130, United States

NOT YET RECRUITING

Weill Cornell Medical College

New York, New York, 10065, United States

NOT YET RECRUITING

Atrium Health/Wake Forest

Charlotte, North Carolina, 28204, United States

RECRUITING

Case Western Reserve University

Cleveland, Ohio, 44106, United States

NOT YET RECRUITING

MetroHealth Medical Center

Cleveland, Ohio, 44109, United States

RECRUITING

Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

RECRUITING

Baylor Scott & White Health

Dallas, Texas, 75204, United States

NOT YET RECRUITING

MeSH Terms

Conditions

Esophageal Achalasia

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PRINCIPAL INVESTIGATOR (Contact PI)

Study Record Dates

First Submitted

December 17, 2025

First Posted

December 19, 2025

Study Start

April 29, 2026

Primary Completion (Estimated)

August 1, 2031

Study Completion (Estimated)

August 1, 2032

Last Updated

July 27, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations